This explains why deletion or hypermethylation of the p16INK4a locus is commonly detected in patients with B-ALL or T-ALL (Malumbres et al., 1999; Ohnishi et al., 1995; Sulong et al., 2009). The gene discussed is CDKN2A; the disease is acute lymphoblastic leukemia.